Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy). According to a report published online today in Diabetes, the transcription factor RUNX1 was found in abnormal retinal blood vessels, and by inhibiting RUNX1 with a small molecule drug, the researchers achieved a 50 percent reduction of retinopathy in preclinical models. These findings pave the way for new therapies that address diabetic retinopathy and other conditions involving abnormal vessel growth within the retina.
https://www.sciencedaily.com/releases/2017/04/170411104510.htm
https://www.sciencedaily.com/releases/2017/04/170411104510.htm